regulatory
confidence high
sentiment positive
materiality 0.30
RenovoRx regains Nasdaq minimum bid price compliance
RenovoRx, Inc.
- Received Nasdaq notice Dec 31, 2025 for bid price below $1.00 for 30 consecutive days.
- Confirmed Aug 20, 2026 that bid price was $1.00+ for 10 straight days (Aug 6-19).
- Nasdaq considers matter closed; company now compliant with Listing Rule 5550(a)(2).